-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCOLYTICS BIOTECH - INITIAL REO 33 PART A TUMOR RESPONSE UPDATE EXPECTED BY YEAR-END 2026; PART B ENROLLMENT MAY BEGIN Q1 2027

Reuters·07/13/2026 13:00:00

Please log in to view news